Personal profile
Expertises
Next Generation Sequencing
Realtime PCR
Main research areas
Human papiloma Virus
Cyto Megalovirus
Epstein Barr Virus
Current research
UGT1A1
HPV
Potential conflicts of interest
none
Fingerprint
Dive into the research topics where Wojciech Skovrider-Ruminski is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
- 9 Journal article
-
No Bacterial Biomass Detected in Tissue From Patients With Ovarian Cancer and Serous Tubal Intraepithelial Carcinomas Using 16S rDNA Sequencing
Ingerslev, K., Poulsen, T. S., Strube, M. L., Skovrider-Ruminski, W., Schledermann, D., Schnack, T. H., Høgdall, C., Blaakær, J. & Høgdall, E., Jan 2025, In: APMIS - Journal of Pathology, Microbiology and Immunology. 133, 1, e13509.Research output: Contribution to journal › Journal article › Research › peer-review
1 Citation (Scopus) -
Pre-and Postoperative Circulating Tumour DNA in Patients With Gastrointestinal Stromal Tumour - A Methodological Assessment Study
Brinch, C. M., Aggerholm-Pedersen, N., Poulsen, T. S., Skovrider-Ruminski, W., DE Heer, P., Penninga, L., Krarup-Hansen, A. & Hogdall, E., Nov 2022, In: Anticancer Research. 42, 11, p. 5527-5537 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
1 Citation (Scopus) -
Frequency and coexistence of KRAS, NRAS, BRAF and PIK3CA mutations and occurrence of MMR deficiency in Danish colorectal cancer patients
Poulsen, T. S., de Oliveira, D. V. N. P., Espersen, M. L. M., Klarskov, L. L., Skovrider-Ruminski, W. & Hogdall, E., Feb 2021, In: APMIS - Journal of Pathology, Microbiology and Immunology. 129, 2, p. 61-69 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
17 Citations (Scopus) -
Oral administration of irinotecan in patients with solid tumors: an open-label, phase I, dose escalating study evaluating safety, tolerability and pharmacokinetics
Kümler, I., Sørensen, P. G., Palshof, J., Høgdall, E., Skovrider-Ruminski, W., Theile, S., Fullerton, A., Nielsen, P. G., Jensen, B. V. & Nielsen, D. L., 31 Jan 2019, In: Cancer Chemotherapy and Pharmacology. 83, 1, p. 169-178 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
17 Citations (Scopus) -
The prevalence of EBV and CMV DNA in epithelial ovarian cancer
Ingerslev, K., Høgdall, E., Skovrider-Ruminski, W., Schnack, T. H., Lidang, M., Høgdall, C. & Blaakaer, J., 2019, In: Infectious Agents and Cancer. 14, p. 7Research output: Contribution to journal › Journal article › Research › peer-review
25 Citations (Scopus)